TMDSAS Reapplicant Acceptance Rate: What the Texas Data Actually Shows

TMDSAS Reapplicant Acceptance Rate: What the Texas Data Actually Shows

If you are reapplying through TMDSAS, you have probably asked the question that nobody seems to answer with numbers: what is the reapplicant acceptance rate at Texas medical schools, and do schools hold reapplying against you?

Search for it and you will find plenty of pages that define what a reapplicant is -- someone who checked the "reapply" box -- and almost nothing that puts a statistic next to it. The official TMDSAS dashboard does not headline a reapplicant acceptance rate, and most premed advice on the topic is national and AMCAS-flavored, not Texas-specific.

So we pulled the Texas numbers directly. Working from the public TMDSAS stats dashboard, we extracted ten completed entry-year cohorts (2016 through 2025) and isolated the reapplicant group. This piece walks through what those numbers say, how the reapplicant rate compares to the overall TMDSAS cohort year by year, and -- most importantly -- why the gap is almost certainly not evidence that Texas schools penalize you for trying again.

The short version, surfaced after a reader pointed us toward independent statistical work on Student Doctor Network: TMDSAS reapplicants do accept at a lower rate than the overall pool, but the gap tracks academic metrics, not a bias against reapplying. The data shows correlation. We infer the cause cautiously, and we will be explicit about where inference begins.

The headline numbers

Across the ten completed cohorts (entry years 2016-2025), reapplicants make up a remarkably stable share of the TMDSAS applicant pool: about 23 to 24 percent every single year. Roughly one in four people applying to Texas medical schools in any given cycle is reapplying. That stability matters. Reapplication is not a fringe event in Texas admissions -- it is a structural, baked-in feature of the system, the same way it is nationally.

Over the full ten-year window, the reapplicant acceptance rate was about 29 percent, compared to about 35 percent for the overall TMDSAS cohort. That is a real gap of roughly six points on aggregate. But the year-by-year picture is more interesting than the average, because the gap moves -- and because the interview data tells a different story than the acceptance data.

Reapplicant acceptance rate vs. overall, by entry year

Here is the core table. "Reapplicant share of pool" is the reapplicant in-group count divided by total applicants that year. "Reapplicant acceptance rate" is reapplicant acceptances divided by reapplicants. "Overall acceptance rate" is total acceptances divided by total applicants, from the headline TMDSAS funnel.

If any of these figures look surprising, you can verify them yourself: every number in this table is computed from our open TMDSAS admissions dataset on GitHub, an independent reproduction of the public TMDSAS stats dashboard.

A few things jump out.

The gap is real but modest, and it has narrowed. In the late 2010s the reapplicant rate ran 8 to 10 points below the overall cohort. From 2021 onward the gap compressed to roughly 2 to 5 points. In entry year 2023, the reapplicant acceptance rate hit 35.7 percent -- within two points of the overall cohort and higher than the overall rate of several earlier years. A 35 percent acceptance rate for a group that, by definition, has already been turned down once is not the profile of a process that punishes reapplying.

Reapplicants are not a small or unusual group. At over 2,000 reapplicants in most recent cycles, this is a large, stable sample -- not a handful of outliers whose rate swings on noise.

We deliberately excluded entry year 2026 from this table. That cycle is still in progress: as of the data extraction, EY2026 acceptances are partial and matriculations are zero, so any rate computed from it would be meaningless. Do not read anything into in-progress numbers.

The interview data flips the "penalty" story

Here is the finding that does the most to undercut the "schools penalize reapplicants" narrative. If Texas schools were screening out reapplicants on sight -- treating the reapply box as a red flag -- you would expect reapplicants to get interviewed at noticeably lower rates than everyone else. They do not.

In the most recent five completed cycles, reapplicants were interviewed at rates that essentially match or exceed the overall cohort. In entry years 2021, 2022, 2023, and 2024, the reapplicant interview rate was actually higher than the overall rate. That is the opposite of what a reapplicant penalty would produce. Schools are inviting reapplicants to interview at least as often as anyone else -- which means the "reapply" box is not functioning as a filter at the screening stage.

So if reapplicants get interviewed at normal-or-better rates but still accept at a somewhat lower rate, the gap is opening up somewhere other than a blanket bias against reapplying. The most parsimonious explanation is the one premed advisors have given for years: the reapplicant pool, on average, carries the application weaknesses that produced the first rejection -- most often a lower MCAT or GPA, or fixable gaps in experience and essays. Those same weaknesses depress conversion at the acceptance stage, where competition is tightest.

Why metrics, not bias, best explain the gap

TMDSAS publishes average academic metrics for its accepted cohort, and the bar is high. For the accepted group in recent completed cycles, the average total MCAT sits around 511-512 and the average overall GPA around 3.80-3.84 (with accepted science GPA close behind). The all-applicant averages are meaningfully lower -- roughly a 506-507 MCAT and a 3.63-3.64 GPA. The accepted cohort is pulled from the top of the metric distribution.

That spread is the whole story. A reapplicant cohort is, almost by construction, weighted toward applicants whose first-cycle metrics sat below the accepted-cohort medians -- that is a common reason the first application did not convert. When a group skews below a 511 MCAT and a 3.80 GPA going in, it will convert at a lower rate at the acceptance stage even if every school is completely neutral about whether someone has applied before. The gap you see in the first table is consistent with a metrics gap, not a penalty.

This is also why the interview data is so telling. Interviews are extended more on the overall strength and fit of a file; acceptances, in a coordinated match against a high-metric accepted cohort, are where raw numbers bite hardest. Reapplicants clearing the interview bar at normal rates but converting at a slightly lower rate is exactly the pattern you would expect if metrics -- not the reapply flag -- were the binding constraint.

To be clear about the limits here: this is correlation, and we are inferring the cause. The TMDSAS data does not break the reapplicant group down by MCAT or GPA band, so we cannot prove the metric-gap mechanism from these tables alone. We are reading it as the most plausible explanation given the high accepted-cohort medians and the normal interview rates, not as a settled causal fact. The honest framing is: the gap appears driven by metrics, not a reapplicant penalty.

The independent SDN analysis: cumulative success across two cycles

A reader pointed us to independent statistical analyses circulating on Student Doctor Network that approach the question from a different angle: not the single-cycle acceptance rate, but the cumulative odds of getting in across two cycles. Those analyses estimate something in the neighborhood of 65 percent cumulative success for reapplicants who go through a second cycle -- meaning that when you account for people who get in on the second try after a first-cycle rejection, the multi-cycle picture looks far more encouraging than any single-year rate suggests.

We are presenting this as independent secondary analysis, not as proven fact, and not as our own dataset. SDN is a community forum, and these estimates depend on assumptions about how many rejected applicants reapply and how their second-cycle odds stack. But the direction is consistent with what the TMDSAS interview data shows: reapplying is a normal, often-successful path, and a first rejection is far from a verdict. If a single-cycle reapplicant acceptance rate near 30 percent feels discouraging, the cumulative framing is the more realistic way to think about your actual odds over a two-cycle horizon.

One caveat that matters: the data can't see what you changed

There is a critical limitation baked into the "reapplicant" flag. In the TMDSAS data, a reapplicant is simply anyone who checked the reapply box -- the source field marks them "Reapplicant." That flag cannot distinguish between two completely different people:

• The applicant who reapplied with real improvements -- a higher MCAT, a finished post-bacc, hundreds of new clinical hours, rewritten essays, a broader school list.
• The applicant who reapplied with essentially the same file -- same scores, same activities, a lightly edited personal statement.

Both check the same box, so both land in the same reapplicant rate. That single aggregate number is being pulled down by the applicants who changed little or nothing -- exactly the group that admissions data, nationally and in Texas, consistently shows gets rejected again. If you are the kind of reapplicant who is reading a data article to figure out what to change, you are already selecting yourself out of the low-conversion subgroup. The aggregate rate is not your rate.

This is the same dynamic we documented in our national companion piece, and it is worth reading alongside this one: see what the acceptance rate data says about reapplying to medical school for the AMCAS/national picture, including the AAMC MCAT-GPA grid and what an MCAT retake actually does to your odds. This article stays in the Texas lane; that one covers the broader U.S. landscape.

What this means if you are reapplying through TMDSAS

The data supports a fairly clear set of takeaways for a Texas reapplicant:

You are not being punished for the box. Reapplicants get interviewed at rates that match or beat the overall cohort. There is no evidence in ten years of TMDSAS data that schools are filtering you out at the screening stage for having applied before. Stop budgeting anxiety for a penalty that the numbers do not show.

The gap is a metrics-and-execution gap, so treat it as one. Because the acceptance-stage gap most plausibly reflects below-median metrics and fixable weaknesses, the highest-leverage moves are the ones that close that gap: a meaningfully higher MCAT if yours sat below the ~511 accepted average, additional clinical or research depth, and essays that read as a genuinely different, stronger candidate rather than a re-skin of last cycle's file.

Think in cumulative terms, not single-cycle terms. A roughly 30 percent single-cycle reapplicant rate, combined with the independent ~65 percent two-cycle estimate, means a well-executed second application is a reasonable bet -- not a long shot.

Do not draw conclusions from EY2026. That cycle is in progress and its numbers are incomplete. Compare yourself to the completed cohorts.

For the full Texas dataset -- the complete admissions funnel, residency breakdowns, and accepted-cohort metrics behind the numbers in this piece -- see our TMDSAS acceptance rates and admissions data deep dive. And if you want to understand how acceptances actually get finalized in Texas, our explainer on how the TMDSAS match system works covers pre-match offers and Match Day in plain English.

The piece that matters most for a reapplicant: what to change

The data says the reapply box itself is not the problem. The first-cycle weaknesses are. For most reapplicants, the single biggest controllable lever is the application narrative -- and in Texas, that means three essays that have to read as a meaningfully different candidate from the one schools saw last year.

Our companion guide on the TMDSAS reapplicant essay strategy covers exactly that: how to address the reapplication directly, what to put in the optional essay, and how to make the Personal Statement and Personal Characteristics Essay show growth rather than repetition. Admissions committees that rejected you once may have your previous essays on file. Submitting something nearly identical signals you have not grown; submitting something demonstrably stronger signals you have.

This is where GradPilot is built to help. It is designed for the kind of strategic, evidence-based rewriting a strong reapplication needs -- helping you produce three TMDSAS essays that are differentiated from each other and clearly stronger than last cycle's, in your own voice. If the data tells you the gap is execution, not bias, the rewrite is the highest-leverage place to spend your reapplication year.

---

About the data: Figures in this article are computed from an open, independent reproduction of TMDSAS's public stats dashboard, available at github.com/7hacker/tmdsas-admissions-data, sourced from the TMDSAS medical statistics dashboard. Data as of entry year 2026; this is an independent reproduction and is not affiliated with or endorsed by TMDSAS. The cumulative-success estimate is drawn from independent statistical analysis shared on Student Doctor Network and is presented as secondary analysis, not as a proven figure. All rates are computed from pre-aggregated public counts; the data cannot separate reapplicants who improved their applications from those who did not.